ANGLE plc is a holding company. The Company's principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health. Its Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. The resulting liquid biopsy (blood test) enables the detection and investigation of mutations in the patient's cancer for personalized cancer care. The harvested CTCs have a range of applications, including diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring.
Industry, Sector and Symbol:
- Sector: Healthcare
- Industry: Bio Therapeutic Drugs
- Sub-Industry: N/A
- Symbol: LON:AGL
- CUSIP: N/A
- Web: www.angleplc.com/
Capitalization:- Market Cap: £38.17 million
- Outstanding Shares: 72,020,000
Average Prices:- 50 Day Moving Avg: GBX 60.61
- 200 Day Moving Avg: GBX 53.32
- 52 Week Range: GBX 44 - GBX 80
P/E:- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
Sales & Book Value:- Annual Revenue: $579,999.00
- Price / Sales: 65.81
- Book Value: GBX 0.18 per share
- Price / Book: 2.94
Profitability:- EBIDTA: ($5,670,000.00)
- Net Margins: -1,228.31%
- Return on Equity: -53.87%
- Return on Assets: -52.68%
Misc:- Average Volume: 214,006 shs.
Frequently Asked Questions for ANGLE plc (LON:AGL)
What is ANGLE plc's stock symbol?
ANGLE plc trades on the London Stock Exchange (LON) under the ticker symbol "AGL."
When will ANGLE plc make its next earnings announcement?
Who are some of ANGLE plc's key competitors?
Some companies that are related to ANGLE plc include ImmuPharma PLC (IMM), Flex Pharma (FLKS), Leap Therapeutics (LPTX), Endocyte (ECYT), Verona Pharma Plc (VRP), Xenon Pharmaceuticals (XENE), Rexahn Pharmaceuticals (RNN), Synthetic Biologics (SYN), Avacta Group Plc (AVCT), Motif Bio PLC (MTFB), Actinium Pharmaceuticals (ATNM), Akari Therapeutics PLC (AKTX), Imprimis Pharmaceuticals (IMMY), OptiBiotix Health PLC (OPTI), Zosano Pharma Corporation (ZSAN), KemPharm (KMPH), pSivida Corp. (PSDV) and Midatech Pharma PLC (MTPH).
Who are ANGLE plc's key executives?
ANGLE plc's management team includes the folowing people:
- Andrew D. W. Newland, Chief Executive, Executive Director
- Ian F. Griffiths, Finance Director, Company Secretary, Executive Director
- Garth R. Selvey, Non-Executive Chairman of the Board
- Brian Howlett, Non-Executive Director
- David W. Quysner CBE, Non-Executive Independent Director
How do I buy ANGLE plc stock?
Shares of ANGLE plc and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is ANGLE plc's stock price today?
One share of ANGLE plc stock can currently be purchased for approximately GBX 53.
MarketBeat Community Rating for ANGLE plc (LON AGL)MarketBeat's community ratings are surveys of what our community members think about ANGLE plc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Consensus Ratings for ANGLE plc (LON:AGL) (How are Consensus Ratings Calculated?) MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
| Ratings Breakdown: | 1 Hold Rating |
| Consensus Rating: | Hold (Score: 2.00) |
| Consensus Price Target: | N/A |
Analysts' Ratings History for ANGLE plc (LON:AGL)
Show:
| Date | Firm | Action | Rating | Price Target | Details |
|---|
| 7/5/2017 | Beaufort Securities | Reiterated Rating | Speculative Buy | |  |
(Data available from 7/26/2015 forward)
Earnings History for ANGLE plc (LON:AGL)Earnings History by Quarter for ANGLE plc (LON AGL)| Date | Quarter | Consensus Estimate | Actual EPS | Revenue Estimate | Actual Revenue | Release Link | Conference Call | Details |
|---|
| 7/27/2017 | Y 2017 | ($0.11) | | | | | N/A | |
(Data available from 1/1/2011 forward)
Earnings Estimates for ANGLE plc (LON:AGL)Current Year EPS Consensus Estimate: $-10.30 EPS
Dividend History for ANGLE plc (LON:AGL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for ANGLE plc (LON:AGL)Insider Trades by Quarter for ANGLE plc (LON:AGL)| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Details |
|---|
| 10/26/2016 | Andrew D Newland | Insider | Buy | 1,350,000 | GBX 57 | £769,500 | |
(Data available from 1/1/2013 forward)
Headline Trends for ANGLE plc (LON:AGL)
Latest Headlines for ANGLE plc (LON:AGL)
| Source: |
|
ANGLE plc (AGL) Chart for Wednesday, July, 26, 2017
